Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.

Colli Pee Novosanis

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Colli-Pee in a box

Improving the quality of home-based urine collection by easy self-sampling, alongside postal packaging

Latest news

CE-IVD marked

Colli-Pee® Small Volumes Products CE Marked

Novosanis achieved two major milestones - our Colli-Pee ® Small Volumes product line is now CE-Marked.

Latest blogpost

HIV prevention and STI detection
Given the disproportionate impact of STIs and HIV on the same populations, more convenient STI testing methods are needed to reach groups at risk. PrEP provides the opportunity to reach people at highest HIV and STI risk, expanding HIV prevention and optimizing STI services. Urine has shown to be a more accepted and effective sample type to detect several STIs.

Upcoming event

Webinar: Accuracy and Validation of pre-analytical and analytical procedures for HPV and STIs testing of self-collected urine samples

Virtual webinar
Register now for an upcoming webinar hosted by Novosanis with Prof. Clementina Cocuzza and Prof. Alex Vorsters, which will highlight the potential of self-collected urine samples for detection of STIs, including Human Papillomavirus (HPV).